Cysteine 138 mutation in HIV-1 Nef from patients with delayed disease progression

Sexual Health

Volumn 3, Issue 4, 2006, Pages 281-286

  Tolstrup, Martin ^a,b   Laursen, Alex L ^a   Gerstoft, Jan ^c   Pedersen, Finn S ^b   Ostergaard, Lars ^a   Duch, Mogens ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; NEF PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANALYTIC METHOD; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE CLUSTER; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MALE; MEDICAL RECORD REVIEW; NUCLEOTIDE SEQUENCE; PHYLOGENY; PREVALENCE; PROTEIN DOMAIN; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; VIRAL GENETICS; VIRUS GENE; VIRUS ISOLATION; VIRUS MUTATION; VIRUS REPLICATION;

ADULT; ALLELES; AMINO ACID SEQUENCE; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; CYSTEINE; DISEASE PROGRESSION; FEMALE; GENES, NEF; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC;

EID: 33751198295     PISSN: 14485028     EISSN: None     Source Type: Journal    
DOI: 10.1071/SH06002     Document Type: Article

References (33)

1. Premkumar DR, Ma XZ, Maitra RK, Chakrabarti BK, Salkowitz J, Yen-Lieberman B et al. The nef gene from a long-term HIV type 1 nonprogressor. AIDS Res Hum Retroviruses 1996; 12(4): 337-45.
2. Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, Martino L et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci USA 2000; 97(6): 2709-14. doi: 10.1073/pnas.050567397
3. Fang G, Kuiken C, Weiser B, Rowland-Jones S, Plummer F, Chen CH et al. Long-term survivors in Nairobi: complete HIV-1 RNA sequences and immunogenetic associations. J Infect Dis 2004; 190(4): 697-701. doi: 10.1086/421504
4. Stewart GJ, Ashton LJ, Biti RA, Ffrench RA, Bennetts BH, Newcombe NR et al. Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian Long-Term Non-Progressor Study Group. AIDS 1997; 11(15): 1833-8.
5. Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, Catano G et al. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 2005; 307(5714): 1434-40. doi: 10.1126/science.1101160
6. Alexander L, Aquino-DeJesus MJ, Chan M, Andiman WA. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by a two-amino-acid insertion in HIV-1 Vif from a nonprogressing mother and child. J Virol 2002; 76(20): 10533-9. doi: 10.1128/JVI.76.20.10533-10539.2002
7. Fang G, Burger H, Chappey C, Rowland-Jones S, Visosky A, Chen CH et al. Analysis of transition from long-term nonprogressive to progressive infection identifies sequences that may attenuate HIV type 1. AIDS Res Hum Retroviruses 2001; 17(15): 1395-404. doi: 10.1089/088922201753197060
8. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 1995; 270(5238): 988-91.
9. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 1995; 332(4): 228-32. doi: 10.1056/NEJM199501263320405
10. Kirchhoff F, Easterbrook PJ, Douglas N, Troop M, Greenough TC, Weber J et al. Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease. J Virol 1999; 73(7): 5497-508.
11. Mariani R, Kirchhoff F, Greenough TC, Sullivan JL, Desrosiers RC, Skowronski J. High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection. J Virol 1996; 70(11): 7752-64.
12. Rhodes DI, Ashton L, Solomon A, Carr A, Cooper D, Kaldor J et al. Characterization of three nef-defective human immunodeficiency virus type 1 strains associated with long-term nonprogression. Australian Long-Term Nonprogressor Study Group. J Virol 2000; 74(22): 10581-8. doi: 10.1128/JVI.74.22.10581-10588.2000
13. Novembre FJ, Lewis MG, Saucier MM, Yalley-Ogunro J, Brennan T, McKinnon K et al. Deletion of the nef gene abrogates the ability of SIV smmPBj to induce acutely lethal disease in pigtail macaques. AIDS Res Hum Retroviruses 1996; 12(8): 727-36.
14. Whatmore AM, Cook N, Hall GA, Sharpe S, Rud EW, Cranage MP. Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence. J Virol 1995; 69(8): 5117-23.
15. Lindemann D, Wilhelm R, Renard P, Althage A, Zinkernagel R, Mous J. Severe immunodeficiency associated with a human immunodeficiency virus 1 NEF/3′-long terminal repeat transgene. J Exp Med 1994; 179(3): 797-807. doi: 10.1084/jem.179.3.797
16. Learmont JC, Geczy AF, Mills J, Ashton LJ, Raynes-Greenow CH, Garsia RJ et al. Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort. N Engl J Med 1999; 340(22): 1715-22. doi: 10.1056/NEJM199906033402203
17. Tolstrup M, Ostergaard L, Laursen AL, Pedersen SF, Duch M. HIV/SIV escape from immune surveillance: focus on Nef. Curr HIV Res 2004; 2(2): 141-51. doi: 10.2174/1570162043484924
18. Benson RE, Sanfridson A, Ottinger JS, Doyle C, Cullen BR. Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection. J Exp Med 1993; 177(6): 1561-6. doi: 10.1084/jem.177.6. 1561
19. Bresnahan PA, Yonemoto W, Ferrell S, Williams-Herman D, Geleziunas R, Greene WC. A dileucine motif in HIV-1 Nef acts as an internalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor. Curr Biol 1998; 8(22): 1235-8. doi: 10.1016/S0960-9822(07)00517-9
20. Piguet V, Chen YL, Mangasarian A, Foti M, Carpentier JL, Trono D. Mechanism of Nef-induced CD4 endocytosis: Nef connects CD4 with the mu chain of adaptor complexes. EMBO J 1998; 17(9): 2472-81. doi: 10.1093/emboj/17.9.2472
21. Stoddart CA, Geleziunas R, Ferrell S, Linquist-Stepps V, Moreno ME, Bare C et al. Human immunodeficiency virus type 1 Nef-mediated downregulation of CD4 correlates with Nef enhancement of viral pathogenesis. J Virol 2003; 77(3): 2124-33. doi: 10.1128/JVI.77.3.2124-2133.2003
22. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987; 4(4): 406-25.
23. Rozanov M, Plikat U, Chappey C, Kochergin A, Tatusova T. A web-based genotyping resource for viral sequences. Nucleic Acids Res 2004; July 1: 32 (online issue):W654-W659.
24. Wu L, Paxton WA, Kassam N, Ruffing N, Rottman JB, Sullivan N et al. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 1997; 185(9): 1681-91. doi: 10.1084/jem.185.9.1681
25. Blagoveshchenskaya AD, Thomas L, Feliciangeli SF, Hung CH, Thomas G. HIV-1 Nef downregulates MHC-I by a PACS-1-and PI3K-regulated ARF6 endocytic pathway. Cell 2002; 111(6): 853-66. doi: 10.1016/S0092-8674(02)01162-5
26. Freund J, Kellner R, Konvalinka J, Wolber V, Krausslich HG, Kalbitzer HR. A possible regulation of negative factor (Nef) activity of human immunodeficiency virus type 1 by the viral protease. Eur J Biochem 1994; 223(2): 589-93. doi: 10.1111/j.1432-1033.1994.tb19029.x
27. Zazopoulos E, Haseltine WA. Mutational analysis of the human immunodeficiency virus type 1 Eli Nef function. Proc Natl Acad Sci USA 1992; 89(14): 6634-8. doi: 10.1073/pnas.89.14.6634
28. Yamada T, Iwamoto A. Comparison of proviral accessory genes between long-term nonprogressors and progressors of human immunodeficiency virus type 1 infection. Arch Virol 2000; 145(5): 1021-7. doi: 10.1007/s007050050692
29. Tobiume M, Takahoko M, Yamada T, Tatsumi M, Iwamoto A, Matsuda M. Inefficient enhancement of viral infectivity and CD4 downregulation by human immunodeficiency virus type 1 Nef from Japanese long-term nonprogressors. J Virol 2002; 76(12): 5959-65. doi: 10.1128/JVI.76.12.5959-5965.2002
30. Leitner T, Foley B, Hahn B, Marx P, McCutchan F, Mellors J et al. HIV sequence compendium 2003. Los Alamos: Theroretical Biology and Biophysics Group, Los Alamos National Laboratory. LA-UR number 04-7420; 2005.
31. Hahn T, Ramakrishnan R, Ahmad N. Evaluation of genetic diversity of human immunodeficiency virus type 1 NEF gene associated with vertical transmission. J Biomed Sci 2003; 10(4): 436-50.
32. Wang B, Spira TJ, Owen S, Lal RB, Saksena NK. HIV-1 strains from a cohort of American subjects reveal the presence of a V2 region extension unique to slow progressors and non-progressors. AIDS 2000; 14(3): 213-23. doi: 10.1097/00002030-200002180-00002
33. McPhee DA, Greenway AL, Holloway G, Smith K, Deacon N, Pemberton L et al. Anomalies in Nef expression within the central nervous system of HIV-1 positive individuals/AIDS patients with or without AIDS dementia complex. J Neurovirol 1998; 4(3): 291-300.